Crossmark

Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine

Crossref DOI link: https://doi.org/10.1038/s41598-025-87711-3

Published Online: 2025-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aroonvuthiphong, Vasurom

Bangphoomi, Norasuthi
Funding

Funding for this research was provided by:

This research was funded by Mahidol University (Fundamental Fund: fiscal year 2023 by National Science Research and Innovation Fund (NSRF)).
License Information

Text and Data Mining valid from 2025-01-25

Version of Record valid from 2025-01-25
More Information

Article History

Received: 13 August 2024

Accepted: 21 January 2025

First Online: 25 January 2025

Declarations

:

: The authors declare no competing interests.

: This study has obtained permission from the MUVS Application for Permission of Animal Care and Use (MUVS-ACU F01). The protocol has been approved with the number MUVF-2022-01-02.

Document is current

Any future updates will be listed below